UK markets closed

Titan Pharmaceuticals, Inc. (TTNP)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
6.46+0.06 (+0.91%)
As of 10:42AM EDT. Market open.
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Assets
Current assets
Cash
Cash and cash equivalents
6,760
2,937
6,037
5,413
-
Total cash
6,760
2,937
6,037
5,413
-
Net receivables
46
36
112
884
-
Inventory
0
106
293
328
-
Other current assets
199
314
480
522
-
Total current assets
8,018
3,603
7,229
7,328
-
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
774
2,000
2,114
3,307
-
Accumulated depreciation
-706
-1,593
-1,397
-2,548
-
Net property, plant and equipment
68
407
717
759
-
Other long-term assets
-
48
48
-
-
Total non-current assets
68
455
765
759
-
Total assets
8,086
4,058
7,994
8,087
-
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
500
-
-
327
-
Accounts payable
348
695
795
1,253
-
Accrued liabilities
519
1,488
323
533
-
Deferred revenues
12
196
295
0
-
Other current liabilities
-
129
1,144
1,960
2,080
Total current liabilities
1,444
2,630
2,669
4,223
-
Non-current liabilities
Long-term debt
-
-
-
332
4,019
Total non-current liabilities
0
65
187
332
-
Total liabilities
1,444
2,695
2,856
4,555
-
Stockholders' equity
Common stock
2
1
10
7
-
Retained earnings
-391,830
-386,261
-376,055
-367,279
-
Total stockholders' equity
6,642
1,363
5,138
3,532
-
Total liabilities and stockholders' equity
8,086
4,058
7,994
8,087
-